- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Stable Growth Stocks
Global Pharmaceuticals & Biotech Stable Growth Stocks
Results
80
80 companies
Exelixis
Market Cap: US$10.2b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$37.41
7D
1.6%
1Y
38.9%
Novartis
Market Cap: CHF 185.9b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 96.02
7D
1.5%
1Y
-0.7%
Johnson & Johnson
Market Cap: US$417.4b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$173.82
7D
1.6%
1Y
8.7%
Merck
Market Cap: US$201.5b
Operates as a healthcare company worldwide.
MRK
US$80.03
7D
0.2%
1Y
-29.5%
Catalyst Pharmaceuticals
Market Cap: US$2.4b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$19.68
7D
-9.4%
1Y
2.0%
Orion Oyj
Market Cap: €9.3b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€66.35
7D
-6.7%
1Y
51.4%
Incyte
Market Cap: US$15.3b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$79.19
7D
1.5%
1Y
29.6%
Genmab
Market Cap: DKK 83.5b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,357.50
7D
-4.0%
1Y
-25.5%
Jamjoom Pharmaceuticals Factory
Market Cap: ر.س11.3b
Manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally.
4015
ر.س161.80
7D
-1.3%
1Y
2.7%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥28.2b
Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.
600329
CN¥42.30
7D
5.1%
1Y
27.0%
Lupin
Market Cap: ₹888.9b
Operates as a pharmaceutical company in India, the United States, and internationally.
500257
₹1,943.80
7D
4.3%
1Y
-7.4%
Waters
Market Cap: US$16.7b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$279.29
7D
-2.2%
1Y
-16.2%
WuXi AppTec
Market Cap: CN¥267.3b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥91.50
7D
-1.9%
1Y
122.1%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥15.3b
Engages in the research and development, production, and sale of ophthalmic drug in the People’s Republic of China.
300573
CN¥62.29
7D
-0.9%
1Y
-18.9%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹455.4b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,589.05
7D
-8.8%
1Y
-8.3%
Kalbe Farma
Market Cap: Rp62.2t
Develops, manufactures, and trades in pharmaceutical products in Indonesia.
KLBF
Rp1,370.00
7D
-3.2%
1Y
-18.0%
Stevanato Group
Market Cap: US$6.5b
Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
STVN
US$21.85
7D
-14.6%
1Y
9.7%
H. Lundbeck
Market Cap: DKK 33.5b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 34.92
7D
3.4%
1Y
-16.3%
ACADIA Pharmaceuticals
Market Cap: US$4.2b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$24.82
7D
3.2%
1Y
62.3%
Otsuka Holdings
Market Cap: JP¥4.1t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥7,860.00
7D
6.0%
1Y
-0.6%
ADMA Biologics
Market Cap: US$3.9b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$16.38
7D
-13.6%
1Y
-5.2%
Medpace Holdings
Market Cap: US$12.2b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$449.77
7D
4.0%
1Y
19.7%
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥31.0b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥50.00
7D
-3.1%
1Y
177.5%
Zhejiang Huahai Pharmaceutical
Market Cap: CN¥30.9b
Operates as a pharmaceutical company in China and internationally.
600521
CN¥20.21
7D
-6.0%
1Y
13.2%
Zhejiang Medicine
Market Cap: CN¥15.1b
Manufactures and sells life nutrition and pharmaceutical products in China.
600216
CN¥15.59
7D
-1.7%
1Y
4.5%
Alkem Laboratories
Market Cap: ₹579.2b
A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.
ALKEM
₹5,149.00
7D
4.6%
1Y
-9.8%
Sai Life Sciences
Market Cap: ₹186.6b
Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.
SAILIFE
₹876.80
7D
10.3%
1Y
n/a
3SBio
Market Cap: HK$72.9b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$30.50
7D
-5.6%
1Y
381.1%
Cipla
Market Cap: ₹1.2t
Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.
CIPLA
₹1,521.60
7D
1.5%
1Y
-3.9%
Abbott India
Market Cap: ₹701.2b
Operates as a pharmaceutical company in India.
500488
₹32,342.10
7D
-2.8%
1Y
18.5%
Santen Pharmaceutical
Market Cap: JP¥492.8b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥1,476.00
7D
-10.5%
1Y
-17.1%
Hisamitsu Pharmaceutical
Market Cap: JP¥306.5b
Manufactures and sells pharmaceuticals in Japan.
4530
JP¥4,314.00
7D
3.5%
1Y
8.5%
PharmaEssentia
Market Cap: NT$166.3b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$503.00
7D
-1.2%
1Y
-31.1%
ALTEOGEN
Market Cap: ₩23.0t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩434,500.00
7D
-2.1%
1Y
48.5%
Hansoh Pharmaceutical Group
Market Cap: HK$210.5b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$36.10
7D
-0.4%
1Y
96.6%
Yunnan Baiyao GroupLtd
Market Cap: CN¥99.9b
Engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally.
000538
CN¥55.95
7D
-0.4%
1Y
3.6%